☆ 4.6 Article

Radiogenomic System for Non-Invasive Identification of Multiple Actionable Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer Based on CT Images

CANCERS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Precision medicine in non-small cell lung cancer: Current applications and future directions

Soo-Ryum Yang et al.

Summary: Advances in biomarkers, targeted therapies, and immuno-oncology have transformed the clinical management of patients with advanced NSCLC. The development of targeted therapies for specific genomic alterations and the emergence of immune-checkpoint therapy have revolutionized treatment options for these patients. However, identification of predictive biomarkers for immune-checkpoint inhibition remains a challenging area of research. The use of biomarkers and alternative genotyping methods has become increasingly integrated into clinical practice.

SEMINARS IN CANCER BIOLOGY (2022)

添加到收藏夹

Article Immunology

Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images

Chengdi Wang et al.

Summary: AI system combining deep learning, radiomics, and clinical features showed promising results in predicting EGFR and PD-L1 status using CT images. The system achieved high AUCs in identifying gene expression status, subtype classification, and joint EGFR-PD-L1 prediction, demonstrating the potential for early intervention in lung cancer treatment.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Oncology

The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy

Matteo Canale et al.

Summary: Non-Small-Cell Lung Cancer (NSCLC) is the leading cause of cancer-related death worldwide. TP53 mutations, the most common mutations in NSCLC, play a significant role in tumor development and treatment responsiveness. This review discusses the role of TP53 in predicting prognosis and responsiveness to targeted therapy in EGFR-mutated NSCLC patients.

CANCERS (2022)

添加到收藏夹

Article Immunology

Non-Invasive Measurement Using Deep Learning Algorithm Based on Multi-Source Features Fusion to Predict PD-L1 Expression and Survival in NSCLC

Chengdi Wang et al.

Summary: An artificial intelligence system using deep learning and radiomics was developed to non-invasively measure PD-L1 expression and predict survival outcomes in lung cancer patients. The combination of deep learning and clinical characteristics improved the prediction capabilities, aiding physicians in making timely treatment decisions.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Oncology

DeepLN: A Multi-Task AI Tool to Predict the Imaging Characteristics, Malignancy and Pathological Subtypes in CT-Detected Pulmonary Nodules

Chengdi Wang et al.

Summary: The DeepLN algorithm based on deep learning shows competitive performance in predicting imaging characteristics, malignancy, and pathologic subtypes of pulmonary nodules based on non-invasive CT images.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Health Care Sciences & Services

Development and validation of an abnormality-derived deep-learning diagnostic system for major respiratory diseases

Chengdi Wang et al.

Summary: In this study, a deep learning-based medical image interpretation system, DeepMRD(TR), was developed for the diagnosis of major respiratory diseases by automatically identifying radiological abnormalities from CT and CXR images. The system showed promise in accurately identifying abnormalities and diagnosing major respiratory diseases, demonstrating potential for clinical application in facilitating early diagnosis and supporting improved clinical decision-making.

NPJ DIGITAL MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study

Kexue Deng et al.

Summary: A deep learning-based system was developed and validated to predict the survival benefits of EGFR-TKIs and ICIs in stage IV NSCLC patients using pre-therapy CT images, facilitating optimized and individualized treatment strategies.

ECLINICALMEDICINE (2022)

添加到收藏夹

Article Medical Informatics

Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study

Shuo Wang et al.

Summary: This study introduced a fully automated artificial intelligence system (FAIS) that mined whole-lung information from CT images to predict EGFR genotype and prognosis with EGFR-TKI treatment. FAIS outperformed tumour-based deep learning models, providing a non-invasive method to detect EGFR genotype and identify high-risk EGFR mutation patients for TKI resistance.

LANCET DIGITAL HEALTH (2022)

添加到收藏夹

Review Oncology

Harnessing multimodal data integration to advance precision oncology

Kevin M. Boehm et al.

Summary: Advancements in quantitative biomarker development have accelerated insights for cancer patients, but integrated approaches across modalities remain underdeveloped. To succeed, efforts in data engineering, computational methods for heterogeneous data analysis, and instantiation of synergistic data models in biomedical research are necessary.

NATURE REVIEWS CANCER (2022)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

Non-Small Cell Lung Cancer, Version 2.2021 Featured Updates to the NCCN Guidelines

David S. Ettinger et al.

Summary: The NCCN Guidelines for NSCLC cover all aspects of management, with recent updates focusing on targeted therapies, immunotherapies, and their respective biomarkers.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

添加到收藏夹

Article Oncology

Deep Learning to Predict EGFR Mutation and PD-L1 Expression Status in Non-Small-Cell Lung Cancer on Computed Tomography Images

Chengdi Wang et al.

Summary: This study proposed a model using radiomics and deep learning techniques to predict EGFR mutation and PD-L1 expression status, showing good performance in survival prediction for NSCLC patients. The combination of deep learning features with clinical features demonstrated great stratification capabilities in the prognostic model. Our team will continue to explore the application of imaging markers for treatment selection of lung cancer patients.

JOURNAL OF ONCOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

AI-based pathology predicts origins for cancers of unknown primary

Ming Y. Lu et al.

Summary: Cancer of unknown primary (CUP) is a difficult diagnosis as the primary site of tumor origin cannot be determined. The deep-learning-based algorithm TOAD provides a differential diagnosis for the origin of the primary tumor, achieving high accuracy on test sets and reducing the occurrence of CUP by assisting in assigning differential diagnoses for complicated cases.

NATURE (2021)

添加到收藏夹

Article Oncology

Simultaneous Identification of EGFR, KRAS, ERBB2, and TP53 Mutations in Patients with Non-Small Cell Lung Cancer by Machine Learning-Derived Three-Dimensional Radiomics

Tiening Zhang et al.

Summary: A machine learning-derived radiomics approach was developed to simultaneously discriminate EGFR, KRAS, ERBB2, and TP53 mutations in NSCLC patients. This noninvasive and low-cost method could be helpful in screening patients before invasive sampling and NGS testing.

CANCERS (2021)

添加到收藏夹

Article Engineering, Biomedical

A deep-learning pipeline for the diagnosis and discrimination of viral, non-viral and COVID-19 pneumonia from chest X-ray images

Guangyu Wang et al.

Summary: An automated deep-learning pipeline was developed for standardizing chest X-ray images, visualizing lesions, and diagnosing diseases, which can identify viral pneumonia caused by COVID-19, assess its severity, and distinguish it from other types of pneumonia. The system showed high discriminative abilities across different types of pneumonia and performed comparably to senior radiologists, indicating its potential to support clinical decision-making and facilitate early intervention.

NATURE BIOMEDICAL ENGINEERING (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Immunotherapy in non-small cell lung cancer: rationale, recent advances and future perspectives

Wenxin Luo et al.

Summary: Lung cancer, especially non-small cell lung cancer (NSCLC), is a major global health issue, with immunotherapy playing a significant role in its treatment. However, not all patients respond effectively to immunotherapy, leading to unconventional responses and challenges that need to be addressed for improved efficacy and safety.

PRECISION CLINICAL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Toward personalized treatment approaches for non-small-cell lung cancer

Meina Wang et al.

Summary: Over the past two decades, molecular targeted therapies and immunotherapies have significantly improved outcomes for non-small-cell lung cancer (NSCLC), but the majority of advanced NSCLCs eventually become resistant. The future challenge lies in the application of predictive biomarkers for patient stratification in order to better manage NSCLC.

NATURE MEDICINE (2021)

添加到收藏夹

Review Oncology

Mutational signatures: emerging concepts, caveats and clinical applications

Gene Koh et al.

Summary: Whole-genome sequencing has enabled the identification of mutational signatures in cancer, shedding light on the causes of individual cancers. Progress has been made in computational, experimental, and clinical directions, but caution is advised in utilizing mutational signature frameworks. Recent developments in the field provide insights into practical issues and challenges in mutational signature analysis for potential clinical applications.

NATURE REVIEWS CANCER (2021)

添加到收藏夹

Correction Biochemistry & Molecular Biology

Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography (vol 181, pg 1423, 2020)

Kang Zhang et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography

Diego Ardila et al.

NATURE MEDICINE (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

A guide to deep learning in healthcare

Andre Esteva et al.

NATURE MEDICINE (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications

Mu Zhou et al.

RADIOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning

Nicolas Coudray et al.

NATURE MEDICINE (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

Miguel F. Sanmamed et al.

CELL (2018)

添加到收藏夹

Review Multidisciplinary Sciences

The biology and management of non-small cell lung cancer

Roy S. Herbst et al.

NATURE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Dermatologist-level classification of skin cancer with deep neural networks

Andre Esteva et al.

NATURE (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates

B. Sacconi et al.

CLINICAL RADIOLOGY (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer

Stefania Rizzo et al.

EUROPEAN RADIOLOGY (2016)

添加到收藏夹

Review Oncology

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

Geoffrey T. Gibney et al.

LANCET ONCOLOGY (2016)

添加到收藏夹

Review Oncology

Defining actionable mutations for oncology therapeutic development

T. Hedley Carr et al.

NATURE REVIEWS CANCER (2016)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

ALK Molecular Phenotype in Non-Small Cell Lung Cancer: CT Radiogenomic Characterization

Shota Yamamoto et al.

RADIOLOGY (2014)

添加到收藏夹

Editorial Material Pediatrics

What is next generation sequencing?

Sam Behjati et al.

ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.